National Medical Insurance Bureau: Strive to launch the alliance reform of local collection of dental implants in the first half of the year

On February 11, the Information Office of the State Council held a regular briefing on State Council policies, at which Chen Jinfu, deputy director of the State Medical Security Bureau, and relevant responsible persons of the Ministry of Industry and Information Technology, the National Health Commission, and the State Drug Administration introduced the progress of deepening the reform of centralized procurement of drugs and high-value medical consumables, and answered reporters' questions.

A reporter asked: What are the specific arrangements for this year for the orthopedic consumables, drug balloons, dental implants and other consumables that were highlighted at the executive meeting of the State Council? Thank you.

Chen Jinfu, deputy director of the National Medical Security Bureau, Source: Dong Ning, China Net

Chen Jinfu: Thank you for your question. This year is mainly several categories, orthopedic consumables this piece, we were recruited last year for artificial hip joints and knee joints, and last year in the trauma category has been the Henan Alliance has carried out recruitment, this year further extended to the spine consumables, so that the largest plate of consumables in the orthopedics this piece of consumables is basically covered. Spinal consumables are now being thoroughly studied and information is being standardized, including its rules. Because the clinical demand for orthopedics is very large, but the standards are different, especially the composition of the product is very complex, so how to form a procurement product group according to the needs of clinical medical treatment, which involves a high technical link, and now in the research program, recently we will conduct special research with the joint procurement office of high-value medical consumables, and widely listen to the opinions of clinical experts, listen to the opinions of enterprises, and strive for a set of preliminary programs in the first half of the year, under mature conditions, this year can smoothly open bids.

The drug balloon involves important consumables in cardiology. After the recruitment of stents the year before, there was a situation in which the use of stents rose, reaching 1.6 times the amount of agreed procurement. At the same time, the use of drug balloons also increased significantly over a period of time. There are also clinical reflections, the price of stents down, doctors do not use stents, this statement is of course not self-defeating, because patients need well, the original excessive abuse of stents this piece, he has no cheap to occupy, not to abuse. At the same time, because the drug balloon is not included in the collection, there is a price space, so this piece also has an inflated component. Last year, we carried out the collection of drug balloons in some places such as Jiangsu, and this year we will expand to the whole country to block the space of inflated heights.

The third piece is dental implants, which are very controversial and criticized a lot. Now it seems that dental implants are an important way to repair missing teeth, and the social demand is also very large. Of course, there are also many services provided by medical institutions. So we think, starting from the local exploration, from the beginning of last year began to deploy, by the Sichuan organization of the interprovincial alliance, study the dental implant collection procedures, now the program is basically mature, but also widely listened to the opinions of clinical, enterprises and localities, ready to strive to launch such a local collection alliance reform in the first half of this year, in fact, it is also a layout under the leadership of the state, a collection method for exploration of dental implants. In fact, in the future, the collection is more important than the rules, the characteristics of different bidding targets are very complex, need to meet the requirements of product quality, but also to meet the clinical needs, but also to effectively allow enterprises and patients to share the results of reform.

I'll just answer so much, thank you.